Aktiesnakken — Januar 2010
-
ja og produktansvar
-
her fra Genmab, der skrives at CHMP har anbefalet betinget markedsføringstilladelse - http://www.genmab.com/en/Press Center/RecentNewsRele
-
skal det ikke medregnes øget risiko for produktansvar
-
sørgelig dag. gad vide, hvornår vi får gode nyheder?
-
det er vel ikke en rist nyhed, bare et lille trin istedetfor i den rigtige retning
-
er Frank syg og praktikanten har taget over?
-
røvribset?
-
fuck his clients!
-
købs anbefaling fra 400 og ned til 116
-
salgsanbefaling fra 70 til 102
-
flot - flot. og jeg må korrigere mig selv. Frank ER røvribset
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind